Literature DB >> 11714221

What in vitro models of infection can and cannot do.

R L White1.   

Abstract

The science of pharmacodynamics analyzes the relationship between an antimicrobial's bactericidal effects and its pharmacokinetics. Ideally, randomized and well-controlled clinical trials are the best way to determine pharmacodynamic properties. However, in vitro models that recapitulate in vivo drug clearance profiles represent an increasingly important technology for carrying out pharmacodynamic studies in a more cost-effective, timely, and easily controlled fashion. Although in vitro pharmacodynamic models cannot incorporate all variables seen in vivo, they do provide valuable information for the drug development process and the determination of optimal dosing regimens.

Mesh:

Substances:

Year:  2001        PMID: 11714221     DOI: 10.1592/phco.21.18.292s.33906

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  11 in total

1.  β-glucan from Saccharomyces cerevisiae is involved in immunostimulation of ovine ruminal explants.

Authors:  Man Zhang; Xin Jin; Yin-Feng Yang; Gui-Fang Cao
Journal:  Can J Vet Res       Date:  2020-10       Impact factor: 1.310

2.  A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of Molecules.

Authors:  Sarah Y Lockwood; Jayda E Meisel; Frederick J Monsma; Dana M Spence
Journal:  Anal Chem       Date:  2016-01-15       Impact factor: 6.986

Review 3.  In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.

Authors:  Pavan K Vaddady; Richard E Lee; Bernd Meibohm
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

4.  New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.

Authors:  Janus A J Haagensen; Davide Verotta; Liusheng Huang; Alfred Spormann; Katherine Yang
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

5.  Drug penetration and metabolism in 3D cell cultures treated in a 3D printed fluidic device: assessment of irinotecan via MALDI imaging mass spectrometry.

Authors:  Gabriel J LaBonia; Sarah Y Lockwood; Andrew A Heller; Dana M Spence; Amanda B Hummon
Journal:  Proteomics       Date:  2016-06       Impact factor: 3.984

Review 6.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Development and evaluation of a porcine in vitro colon organ culture technique.

Authors:  Matheus O Costa; John C S Harding; Janet E Hill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-23       Impact factor: 2.416

8.  Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.

Authors:  Christopher R Frei; Nathan P Wiederhold; David S Burgess
Journal:  J Antimicrob Chemother       Date:  2008-02-04       Impact factor: 5.790

9.  Immunomodulatory Effect of Rhaphidophora korthalsii on Natural Killer Cell Cytotoxicity.

Authors:  Swee Keong Yeap; Abdul Rahman Omar; Abdul Manaf Ali; Wan Yong Ho; Boon Kee Beh; Noorjahan Banu Alitheen
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-15       Impact factor: 2.629

Review 10.  Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond.

Authors:  Sara Saturni; Marco Contoli; Antonio Spanevello; Alberto Papi
Journal:  Allergy Asthma Immunol Res       Date:  2015-07-07       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.